G1 Therapeutics Inc banner

G1 Therapeutics Inc
SWB:G1H

Watchlist Manager
G1 Therapeutics Inc Logo
G1 Therapeutics Inc
SWB:G1H
Watchlist
Price: 6.39 EUR Market Closed
Market Cap: €853.5m

Wall St Price Targets

G1H Price Targets Summary
G1 Therapeutics Inc

There are no price targets for G1H.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
G1 Therapeutics Inc Competitors:
Price Targets
VAC
Pierre et Vacances SA
22% Upside
VINP
Vinci Partners Investments Ltd
34% Upside

Revenue
Forecast

88% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
88% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is G1H's stock price target?
Not Available

G1H does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for G1 Therapeutics Inc?
Projected CAGR
10%

Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett